|
Re: Patents
|
4
|
Resverlogix Corp.
|
Sep 29, 2022 04:17PM
|
|
Re: AGM & PP
|
4
|
Resverlogix Corp.
|
Nov 24, 2020 06:42AM
|
|
Re: Bear
|
4
|
Resverlogix Corp.
|
Jan 15, 2020 09:23AM
|
|
Re: Collaborating with the Supreme Council of the Arab-African Economy
|
4
|
Resverlogix Corp.
|
Nov 03, 2021 03:57PM
|
|
Re: Seems to be some interest
|
4
|
Resverlogix Corp.
|
Apr 13, 2022 09:43AM
|
|
Re: Top Shareholders of RVX
|
4
|
Resverlogix Corp.
|
Mar 01, 2020 12:50PM
|
|
Re: Trials and statistics, next steps
|
4
|
Resverlogix Corp.
|
Feb 12, 2020 07:58AM
|
|
Merck (MRK) Stops MK-7110 Development, Focuses on Molnupiravir
|
4
|
Resverlogix Corp.
|
Apr 19, 2021 09:08AM
|
|
Re: Seems to be some interest
|
4
|
Resverlogix Corp.
|
Apr 13, 2022 10:27AM
|
|
Re: Third Eye Loan
|
4
|
Resverlogix Corp.
|
Dec 28, 2018 09:52AM
|
|
Re: News on 250 Events, Third Eye - Now what? Anything before Top-Line?
|
4
|
Resverlogix Corp.
|
May 06, 2019 01:33PM
|
|
Re: Right of first refusal
|
4
|
Resverlogix Corp.
|
Mar 04, 2019 06:10AM
|
|
Re: Funds
|
4
|
Resverlogix Corp.
|
Feb 18, 2023 10:51AM
|
|
Re: Resverlogix Confirms Interim Filings on SEDAR
|
4
|
Resverlogix Corp.
|
Oct 04, 2020 06:26AM
|
|
Re: China- 1 Million daily COVID cases
|
4
|
Resverlogix Corp.
|
Dec 29, 2022 10:42AM
|
|
Zenith shares
|
4
|
Zenith Epigenetics
|
Nov 04, 2019 10:57AM
|
|
Re: OTC Trading questions
|
4
|
Zenith Epigenetics
|
Mar 02, 2022 09:24AM
|
|
Re: Where do we go from here?
|
4
|
BIOASIS TECHNOLOGIES INC
|
Mar 30, 2021 09:31AM
|
|
Re: Excerpt of a recent Bloomberg article......
|
4
|
Resverlogix Corp.
|
Jan 15, 2020 01:24PM
|
|
Re: IR response
|
4
|
Resverlogix Corp.
|
Jan 12, 2022 07:55AM
|
